Natriumvalproat

Natriumvalproat is a medication primarily used in the treatment of epilepsy and bipolar disorder. It is also prescribed for preventing migraine headaches. The drug belongs to a class of compounds known as anticonvulsants or mood stabilizers. Its exact mechanism of action is not fully understood, but it is believed to work by increasing the levels of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain. This action helps to calm neuronal activity, reducing the occurrence of seizures and stabilizing mood swings.

The medication is available under various brand names, such as Depakine, and comes in several forms, including tablets, capsules, and liquid. Treatment must be initiated and monitored by a healthcare professional due to potential serious side effects. Common adverse effects can include nausea, drowsiness, dizziness, and tremor. More serious risks involve liver damage, pancreatitis, and a decrease in blood platelets. Regular blood tests are often required to monitor liver function and blood counts.

Natriumvalproat carries significant risks if used during pregnancy, as it can cause birth defects and developmental problems in the child. It is therefore contraindicated in women of childbearing potential unless strict conditions are met. Patients should not stop taking the medication abruptly, as this can lead to a worsening of conditions or withdrawal seizures. It is important for individuals to discuss their full medical history with their doctor before starting treatment with this drug.